Cancer news source

• share
• favorite_border

Dr. Jeremie Calais received two grants from Novartis totaling $4 million aimed at improving the effectiveness of the radiation-emitting targeted therapy 177-Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC), one of the most challenging forms of the disease.

• share
• favorite_border

UCLA investigators have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient.

• share
• favorite_border

Open Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals configuration options Historically, some patients with blood cancers have been less likely than others to receive stem cell transplant, also known as bone marrow transplant.

• share
• favorite_border

Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune system, which is part of the body's "smart system" that monitors for threats and fights them with customized defenses.

• share
• favorite_border

Hunter doesn’t remember much from his time at Children’s Hospital Los Angeles, but more than a decade later, one small moment has stuck with him in multiple ways.A blonde woman asks him: “She’d hold up an array of ChapSticks,” Hunter explains, “blueberry, strawberry, green apple, root beer float and chocolate.”

• share
• favorite_border

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer. The results, which were recently published in JAMA Oncology, show potential to broaden the number of patients with bladder cancer who could benefit from immunotherapy, an approach that harnesses a patient's own immune system to fight cancer.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

• share
• favorite_border

By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have found that activation of the MYC gene — a well-known cancer-causing gene — sets off a cascade of events that leads to both initiation and progression of the disease.

• share
• favorite_border

Michigan Medicine will launch a new era in comprehensive breast cancer care, thanks to a generous donation from the Weiser Charitable Foundation

• share
• favorite_border

Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center have been awarded a $1.14M grant from the U.S. Department of Veterans Affairs to use artificial intelligence (AI) to determine the best personalized treatment for Veterans with rectal cancer.

• share
• favorite_border

Los tratamientos para los cánceres de la sangre están evolucionando, ofreciendo más opciones a las personas que viven con la enfermedad.

• share
• favorite_border

• share
• favorite_border

CLEVELAND: A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in 5,000 people worldwide.

• share
• favorite_border

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, announced today that the School of Medicine has been awarded $2 million in matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, totaling $4 million when combined with UMB qualified funding, will enable the establishment of three endowed research professorships.

• share
• favorite_border

New research from Memorial Sloan Kettering Cancer Center (MSK) uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.

• share
• favorite_border